Brad Gray

Brad has served as a member of the board of directors and as president and chief executive officer of NanoString since June 2010. 

Before joining NanoString, Brad was vice president of Product and Business Development at Genzyme Genetics, the diagnostics division of biotechnology pioneer Genzyme, where he led the development of molecular diagnostics and partnering activities. Before that role, he worked in Genzyme’s Corporate Development group and ran Genzyme Ventures. Prior to Genzyme, Brad was a management consultant in the healthcare practice of McKinsey & Company.

Brad received a BA in Economics and Management from Oxford University, where he studied as a British Marshall Scholar. He also earned an SB in Chemical Engineering from the Massachusetts Institute of Technology.